FDA.reportPublic FDA data

Oxcarbazepine

Product NDC
50090-3961
11-digit product format
500903961
Labeler code
50090
Product ID
50090-3961_81ab1371-4617-4376-8776-1c9ee1bd854b
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Oxcarbazepine
Dosage form
TABLET, FILM COATED
Route
ORAL
Labeler
A-S Medication Solutions
Application
ANDA077802
Marketing category
ANDA
Marketing start
2007-10-09
Marketing end
0000-00-00
Substance
OXCARBAZEPINE
Active strength
300 mg/1
Pharmacologic classes
Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE]
NDC exclude flag
No
Listing certified through
2019-12-31
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded productproduct50090-3961DDiscontinued by firm2026-07-31
excluded packagepackage50090-396150090-3961-0DDiscontinued by firm2026-07-31

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A077802-001OXCARBAZEPINEOXCARBAZEPINE150MGTABLET / ORALAB2007-10-09
A077802-002OXCARBAZEPINEOXCARBAZEPINE300MGTABLET / ORALAB2007-10-09
A077802-003OXCARBAZEPINEOXCARBAZEPINE600MGTABLET / ORALAB2007-10-09

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Application-product, TE code table
Application-productTE code
A077802-001AB
A077802-002AB
A077802-003AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-08-01 22:54:322026-06A077802-001OXCARBAZEPINE150MGTABLET / ORALAB2007-10-09a50c72e98297…
2026-08-01 22:54:322026-06A077802-002OXCARBAZEPINE300MGTABLET / ORALAB2007-10-09a50c72e98297…
2026-08-01 22:54:322026-06A077802-003OXCARBAZEPINE600MGTABLET / ORALAB2007-10-09a50c72e98297…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-08-01 22:54:322026-06A077802-001AB1a50c72e98297…
2026-08-01 22:54:322026-06A077802-002AB1a50c72e98297…
2026-08-01 22:54:322026-06A077802-003AB1a50c72e98297…

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 7 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
OxcarbazepineOXCARBAZEPINECoupler LLC51008af2-39ac-546c-e063-6294a90a758f2026-05-04Warnings, Adverse reactionsExact identifier
application applno (ANDA): 077802
application number: ANDA077802
OxcarbazepineOXCARBAZEPINECoupler LLC50873ef7-3deb-7386-e063-6394a90a9c192026-04-28Warnings, Adverse reactionsExact identifier
application applno (ANDA): 077802
application number: ANDA077802
OxcarbazepineOXCARBAZEPINEREMEDYREPACK INC.a90cd1f1-5258-4b0e-92fd-c4cebe47772b2026-04-06Warnings, Adverse reactionsExact identifier
application applno (ANDA): 077802
application number: ANDA077802
OxcarbazepineOXCARBAZEPINEREMEDYREPACK INC.a2032bcc-2da5-45e5-aa3f-ddbf50909df82026-02-17Warnings, Adverse reactionsExact identifier
application applno (ANDA): 077802
application number: ANDA077802
OxcarbazepineOXCARBAZEPINEGlenmark Pharmaceuticals Inc., USA1c713b59-a628-42e6-b166-ae71c39132842025-12-03Warnings, Adverse reactionsExact identifier
application applno (ANDA): 077802
application number: ANDA077802
OxcarbazepineOXCARBAZEPINEDirect_rx21b0cc84-b64a-75de-e063-6294a90a9dd02024-09-09Warnings, Adverse reactionsExact identifier
application applno (ANDA): 077802
application number: ANDA077802
OxcarbazepineOXCARBAZEPINEProficient Rx LP95867dcd-fd0e-4570-987b-d35939f7d7d12022-11-01Warnings, Adverse reactionsExact identifier
application applno (ANDA): 077802
application number: ANDA077802